Brind.

Lin Shu-fen reports that listings are sourced from China, leading the FDA to cooperate with LINE on takedown procedures and consider tighter controls on imports.

1 report, 1 independent Updated Jun 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Lin Shu-fen reports that listings are sourced from China, leading the FDA to cooperate with LINE on takedown procedures and consider tighter controls on imports.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped